Brainstorm Cell Therapeutics (BCLI) Return on Equity [ROE] (2011 - 2022)
Brainstorm Cell Therapeutics (BCLI) reported Return on Equity [ROE] of -304.06% for FY2022, down 214.51 percentage points from -89.55% in FY2021.
Powered by 
Analysis
Brainstorm Cell Therapeutics (BCLI) Return on Equity [ROE] (2011 - 2022) Analysis & Trends
Dating back to FY2011, Brainstorm Cell Therapeutics' Return on Equity [ROE] record includes 11 years.
- Return on Equity [ROE] has a five-year change of -240.71 percentage points (FY2017 to FY2022).
- The FY2022 figure ranks as the lowest annual Return on Equity [ROE] since FY2011.
- According to Business Quant data, Return on Equity [ROE] came in at -89.55% in FY2021 (+183.11 pp), -272.66% in FY2020 and -258.13% in FY2018 (-194.78 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,171.37 Bn | 1,139.96 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 645.23 Bn | 565.09 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 502.25 Bn | 475.37 Bn | 12.70 Bn | - |
| 4 | Merck | 361.34 Bn | 315.71 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 302.82 Bn | 266.81 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 267.91 Bn | 241.60 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 242.39 Bn | 197.79 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 193.55 Bn | 167.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 172.05 Bn | 118.70 Bn | 10.94 Bn | 4.97% |
| 10 | Brainstorm Cell Therapeutics | 8.50 Mn | 8.43 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | -565.41% |
| Jun 30, 2022 | -219.85% |
| Mar 31, 2022 | -136.48% |
| Dec 31, 2021 | -110.87% |
| Sep 30, 2021 | -108.24% |
| Jun 30, 2021 | -87.46% |
| Mar 31, 2021 | -84.57% |
| Dec 31, 2020 | -103.13% |
| Sep 30, 2020 | -155.63% |
| Jun 30, 2020 | -307.16% |
| Mar 31, 2019 | -624.63% |
| Dec 31, 2018 | -187.58% |
| Sep 30, 2018 | -73.41% |
| Jun 30, 2018 | -90.36% |
| Mar 31, 2018 | -113.98% |
| Dec 31, 2017 | -90.28% |
| Sep 30, 2017 | -94.31% |
| Jun 30, 2017 | -66.09% |
| Mar 31, 2017 | -55.56% |
| Dec 31, 2016 | -49.76% |
API Access
Brainstorm Cell Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BCLI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "BCLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BCLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();